14 Oct 2009 16:43
| For immediate release | 14 October 2009 |
Futura Medical plc
("Futura" or "the Group" or "the Company")
Notification of major interest in shares
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Futura Medical plc |
| 2. Reason for the notification | |
| An acquisition or disposal of voting rights | Yes |
| 3. Full name of person(s) subject to the notification obligation: | Brookwell Limited |
| 4. Full name of shareholder(s) (if different from 3.): | Nortrust Nominees Limited |
| 5. Date of the transaction and date on which the threshold is crossed or reached: | 13 October 2009 |
| 6. Date on which issuer notified: | 14 October 2009 |
| 7. Threshold(s) that is/are crossed or reached: | <6% |
| 8. Notified details: |
| A: Voting rights attached to shares | |||||||
| Class/type of shares if possible using the ISIN CODE | Situation previous to the Triggering transaction | Resulting situation after the triggering transaction | |||||
| Number of Shares | Number of Voting Rights | Number of shares Direct | Number of voting rights | % of voting rights | |||
| Direct | Indirect | Direct | Indirect | ||||
| Ordinary Shares GB0033278473 | 3,758,835 | 6.00% | 3,708,835 | 5.92% | 5.92% | ||
| B: Financial Instruments | ||||
| Resulting situation after the triggering transaction | ||||
| Type of financial instrument | Expiration date | Exercise/ Conversion Period/ Date | Number of voting rights that may be acquired if the instrument is exercised/ converted | % of voting rights |
| None |
|
|
|
|
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||
| Resulting situation after the triggering transaction | ||||
| Type of financial instrument | Exercise price | Expiration date | Number of voting rights instrument refers to | % of voting rights |
| None | ||||
| Total (A+B+C) | |
| Number of voting rights | % of voting rights |
|
3,708,835 | 5.92% |
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
| None |
| Proxy Voting: | |
| 10. Name of the proxy holder: | N/A |
| 11. Number of voting rights proxy holder will cease to hold: | N/A |
| 12. Date on which proxy holder will cease to hold voting rights: | N/A |
| 13. Additional information: | Progressive AIM Realisation Limited is Investment Manager to Brookwell Limited |
| 14. Contact name: | Russell Scott |
| 15. Contact telephone number: | 020 7490 4355 |
For further information:
| Futura Medical plc | |
| James Barder, Chief Executive | Tel: +44 (0) 1483 685 670 |
| mail to: james.barder@futuramedical.co.uk | www.futuramedical.co.uk |
| Nomura Code Securities Limited | |
| Charles Walker / Giles Balleny | Tel: +44 (0) 20 7776 1200 |
| For media enquiries please contact: | |
| Buchanan Communications | |
| Mark Court / Jennie Spivey / Stasa Filiplic | Tel: +44 (0) 20 7466 5000 |
Futura Medical (FUM)